Exercise Cardiovascular Magnetic Resonance In Heart Failure With Preserved Ejection Fraction

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-80
SponsorMayo Clinic

About this trial

The purpose of this study is to internally validate low-field Ex-CMR as a noninvasive tool for diagnosing, phenotyping, and risk stratifying HFpEF in patients with exertional dyspnea.

Eligibility criteria

Qualifiers

Informed consent obtained

HFpEF (cardiologist-adjudicated diagnosis as verified by PI, EF≥50%)

Non-cardiac dyspnea (patients have dyspnea but were found on invasive exercise testing not to have HFpEF).

Healthy volunteers with no history of dyspnea or effort intolerance.

Disqualifiers

Contraindication for low-field CMR, as indicated in MRI safety screening checklist (Research Document #1)

Patient inability or unwillingness to undergo Ex-CMR

Cardiac implants, mechanical or biological valve, causing artifacts that compromise the quality of data

Hospitalization for heart failure in the preceding 30 days.

Trial design

Treatments tested in this trial

  • Exercise Cardiovascular Magnetic Resonance

Treatment groups

400 Participants
are divided into 3 treatment groups

Sponsors and collaborators